Nordea Investment Management
TEVA icon

Nordea Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.74M Sell
102,902
-43,767
-30% -$738K ﹤0.01% 748
2025
Q1
$2.21M Buy
146,669
+50,313
+52% +$760K ﹤0.01% 681
2024
Q4
$2.14M Hold
96,356
﹤0.01% 679
2024
Q3
$1.71M Buy
96,356
+4,519
+5% +$80.4K ﹤0.01% 722
2024
Q2
$1.5M Hold
91,837
﹤0.01% 743
2024
Q1
$1.3M Buy
91,837
+2,701
+3% +$38.2K ﹤0.01% 779
2023
Q4
$931K Buy
89,136
+1,521
+2% +$15.9K ﹤0.01% 838
2023
Q3
$902K Sell
87,615
-130,573
-60% -$1.34M ﹤0.01% 828
2023
Q2
$1.66M Sell
218,188
-20,146
-8% -$153K ﹤0.01% 730
2023
Q1
$2.11M Buy
238,334
+3,858
+2% +$34.1K ﹤0.01% 668
2022
Q4
$2.16M Buy
234,476
+162,970
+228% +$1.5M ﹤0.01% 659
2022
Q3
$570K Sell
71,506
-10,019
-12% -$79.9K ﹤0.01% 874
2022
Q2
$620K Buy
81,525
+16,106
+25% +$122K ﹤0.01% 871
2022
Q1
$608K Hold
65,419
﹤0.01% 875
2021
Q4
$533K Buy
65,419
+5,106
+8% +$41.6K ﹤0.01% 909
2021
Q3
$597K Hold
60,313
﹤0.01% 893
2021
Q2
$597K Hold
60,313
﹤0.01% 891
2021
Q1
$687K Sell
60,313
-51,737
-46% -$589K ﹤0.01% 848
2020
Q4
$1.08M Hold
112,050
﹤0.01% 748
2020
Q3
$1.02M Sell
112,050
-96,174
-46% -$873K ﹤0.01% 722
2020
Q2
$2.51M Buy
208,224
+108,715
+109% +$1.31M ﹤0.01% 692
2020
Q1
$898K Hold
99,509
﹤0.01% 722
2019
Q4
$990K Hold
99,509
﹤0.01% 750
2019
Q3
$676K Hold
99,509
﹤0.01% 800
2019
Q2
$919K Sell
99,509
-2,361
-2% -$21.8K ﹤0.01% 774
2019
Q1
$1.6M Buy
101,870
+2,172
+2% +$34.1K ﹤0.01% 902
2018
Q4
$1.54M Buy
99,698
+189
+0.2% +$2.91K ﹤0.01% 887
2018
Q3
$2.14M Buy
+99,509
New +$2.14M ﹤0.01% 874
2018
Q2
Sell
-72,824
Closed -$1.25M 1074
2018
Q1
$1.25M Hold
72,824
﹤0.01% 814
2017
Q4
$1.38M Sell
72,824
-102,553
-58% -$1.94M ﹤0.01% 757
2017
Q3
$3.09M Sell
175,377
-12,709,433
-99% -$224M 0.01% 502
2017
Q2
$428M Buy
12,884,810
+311,894
+2% +$10.4M 1.08% 28
2017
Q1
$403M Sell
12,572,916
-687,495
-5% -$22.1M 1.07% 27
2016
Q4
$481M Buy
13,260,411
+231,069
+2% +$8.38M 1.27% 22
2016
Q3
$599M Buy
13,029,342
+309,593
+2% +$14.2M 1.55% 14
2016
Q2
$639M Buy
12,719,749
+1,543,748
+14% +$77.5M 1.79% 13
2016
Q1
$598M Buy
11,176,001
+5,745,869
+106% +$307M 1.8% 12
2015
Q4
$356M Buy
5,430,132
+1,745,928
+47% +$115M 1.21% 23
2015
Q3
$208M Sell
3,684,204
-870,735
-19% -$49.2M 0.77% 34
2015
Q2
$269M Buy
4,554,939
+65,085
+1% +$3.85M 0.94% 29
2015
Q1
$280M Buy
4,489,854
+250,691
+6% +$15.6M 1% 30
2014
Q4
$244M Buy
4,239,163
+1,402,014
+49% +$80.6M 0.9% 33
2014
Q3
$152M Buy
2,837,149
+1,023,299
+56% +$55M 0.61% 49
2014
Q2
$95.1M Buy
1,813,850
+98,614
+6% +$5.17M 0.4% 71
2014
Q1
$90.6M Sell
1,715,236
-1,755,986
-51% -$92.8M 0.42% 58
2013
Q4
$139M Sell
3,471,222
-1,246,216
-26% -$49.9M 0.69% 45
2013
Q3
$178M Buy
4,717,438
+429,670
+10% +$16.2M 0.99% 25
2013
Q2
$168M Buy
+4,287,768
New +$168M 1.04% 24